Efficacy and safety of intensity-modulated radiotherapy alone versus intensity-modulated radiotherapy plus chemotherapy for treatment of intermediate-risk nasopharyngeal carcinoma

[1] Wi W(2005)Nasopharyngeal carcinoma Lancet 365 2041-2054

[2] Sham JS(2015)Management of nasopharyngeal carcinoma: current practice and future perspective J Clin Oncol 33 3356-3364

[3] Lee AW(2005)Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma J Natl Cancer Inst 97 536-539

[4] Ma BB(2011)Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial J Natl Cancer Inst 103 1761-1770

[5] Ng WT(2012)The seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma is prognostically useful for patients treated with intensity-modulated radiotherapy from an endemic area in China Radiother Oncol 104 331-337

[6] Chan AT(2017)The changing therapeutic role of chemo-radiotherapy for loco-regionally advanced nasopharyngeal carcinoma from two/three-dimensional radiotherapy to intensity-modulated radiotherapy: a network meta-analysis Theranostics 7 4825-4835

[7] Chan AT(2018)Suggestions for surveillance and radiation strategy in nasopharyngeal carcinoma treated with IMRT: based on hazard-rate and patterns of recurrence Oral Oncol 76 61-67

[8] Leung SF(2012)Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system BMC Cancer 12 68-2595

[9] Ngan RK(2015)Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: a 10-year experience with a large cohort and long follow-up Eur J Cancer 51 2587-1474

[10] Chen QY(2010)The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM Ann Surg Oncol 17 1471-247

[1] Wi W(2005)Nasopharyngeal carcinoma Lancet 365 2041-2054

[2] Sham JS(2015)Management of nasopharyngeal carcinoma: current practice and future perspective J Clin Oncol 33 3356-3364

[3] Lee AW(2005)Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma J Natl Cancer Inst 97 536-539

[4] Ma BB(2011)Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial J Natl Cancer Inst 103 1761-1770

[5] Ng WT(2012)The seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma is prognostically useful for patients treated with intensity-modulated radiotherapy from an endemic area in China Radiother Oncol 104 331-337

[6] Chan AT(2017)The changing therapeutic role of chemo-radiotherapy for loco-regionally advanced nasopharyngeal carcinoma from two/three-dimensional radiotherapy to intensity-modulated radiotherapy: a network meta-analysis Theranostics 7 4825-4835

[7] Chan AT(2018)Suggestions for surveillance and radiation strategy in nasopharyngeal carcinoma treated with IMRT: based on hazard-rate and patterns of recurrence Oral Oncol 76 61-67

[8] Leung SF(2012)Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system BMC Cancer 12 68-2595

[9] Ngan RK(2015)Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: a 10-year experience with a large cohort and long follow-up Eur J Cancer 51 2587-1474

[10] Chen QY(2010)The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM Ann Surg Oncol 17 1471-247